DR. DAVID S RUBENSTEIN, MD
Dermatology at Manning Dr, Chapel Hill, NC
License number
North Carolina 9401322
Category
Osteopathic Medicine
Type
Dermatology
Address
Address
101 Manning Dr, Chapel Hill, NC 27599
Phone
(919) 966-4996
(919) 843-5515 (Fax)
(919) 843-5515 (Fax)
Organization information
See more information about DAVID S RUBENSTEIN at bizstanding.comUnc Clinic - David S Rubenstein MD
101 Manning Dr #7001J, Chapel Hill, NC 27514
Categories:
Dermatology Physicians & Surgeons, Physicians & Surgeons
Phone:
(919) 966-7890 (Phone)
Professional information
Dr. David S Rubenstein, Chapel Hill NC - MD (Doctor of Medicine)
Specialties:
Dermatology
Address:
University N Carolina Derm Cntr
410 Market St STE 400, Chapel Hill 27516
(919) 966-2485 (Phone)
410 Market St STE 400, Chapel Hill 27516
(919) 966-2485 (Phone)
Certifications:
Dermatology, 2006
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
University N Carolina Derm Cntr
410 Market St STE 400, Chapel Hill 27516
University of North Carolina Hospital
101 Manning Dr, Chapel Hill 27514
410 Market St STE 400, Chapel Hill 27516
University of North Carolina Hospital
101 Manning Dr, Chapel Hill 27514
Education:
Medical School
Duke University
Graduated: 1992
University Of Mi Hosps and Health Ctrs
University Of Nc Hosps
Duke University
Graduated: 1992
University Of Mi Hosps and Health Ctrs
University Of Nc Hosps
Inhibition Of Hsp27 Phosphorylation For The Treatment Of Blistering Disorders
US Patent:
8008093, Aug 30, 2011
Filed:
Dec 2, 2005
Appl. No.:
11/791903
Inventors:
David Scott Rubenstein - Chapel Hill NC, US
Paula Berkowitz - Chapel Hill NC, US
Peiqi Hu - Chapel Hill NC, US
Luis Alberto Diaz - Chapel Hill NC, US
Paula Berkowitz - Chapel Hill NC, US
Peiqi Hu - Chapel Hill NC, US
Luis Alberto Diaz - Chapel Hill NC, US
Assignee:
The University of North Carolina at Chapel Hill - Chapel Hill NC
International Classification:
G01N 33/564
US Classification:
436506
Abstract:
A method of treating a blistering disorder, which includes administering to a target tissue in a subject in need thereof an effective amount of a composition that inhibits activation of the HSP27 phosphorylation pathway.